Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 74 results found. Search for [ COVID-19 vaccine Sanofi ]

Results 40 to 60 of 74
BusinessToday.In
July 8, 2020
Coronavirus vaccine update: Twelve hospitals have been chosen for COVAXIN trials in the country. Bharat Biotech's COVAXIN is undergoing quality and safety tests before the doses are administered to volunteers


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: A coronavirus vaccine candidate tested by American firm Pfizer and German biotech major BioNTech SE has been found to generate antibodies in people, a study showed


BusinessToday.In
July 2, 2020
Coronavirus Vaccine Latest News: With the news of the Oxford University-AstraZeneca vaccine in its last stage of clinical trials, hopes are high for an earlier than expected arrival of a COVID-19 vaccine


Reuters
July 2, 2020
BioNTech said testing of two dosages of its BNT162b1 drug on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people


E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021


BusinessToday.In
June 30, 2020
Coronavirus vaccine update: The Hyderabad-based vaccine major's vaccine candidate COVAXIN has received permission for advancing to human trials


BusinessToday.In
June 29, 2020
With the news of the Oxford University-AstraZeneca vaccine in its last-stage trial, the world is hopeful of an earlier than expected arrival of a COVID-19 vaccine


Rupa Burman Roy
June 29, 2020
AstraZeneca Pharma India stock has gained 9.9% in one week, 17% in one month and 35% since the beginning of the year.


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


BusinessToday.In
New Delhi, June 25, 2020
Coronavirus vaccine news: Johnson and Johnson has expedited its trials for the COVID vaccine. The final stage of the trial expected to begin in September has been pushed up to the second half of July


Reuters
June 25, 2020
Even with no existing approved vaccines, CEPI is already getting manufacturing and supply chains lined up in a quest to ensure coronavirus vaccines are distributed equitably around the globe


BusinessToday.In
New Delhi, June 24, 2020
Coronavirus vaccine news: Researchers at Imperial College London have administered their coronavirus vaccine to the first healthy volunteer; South Africa has initiated clinical trials of the University of Oxford candidate


Reuters
June 23, 2020
Sanofi Chief Executive Paul Hudson said the firsts in the race now were not assured of securing victory


BusinessToday.In
June 16, 2020
Coronavirus vaccine update: British drugmaker AstraZeneca has reached a deal with New Jersey-based Catalent to help with the final stages of the manufacturing of coronavirus vaccine


Associated Press
June 14, 2020
AstraZeneca plans to begin delivering the vaccine to European countries by the end of this year under the agreement with the Inclusive Vaccine Alliance, formed this month by France, Germany, Italy and the Netherlands


BusinessToday.In
New Delhi, June 11, 2020
Coronavirus vaccine update: Johnson and Johnson has said that it has pushed up clinical trials by two months; Japanese biotech company AnGes Inc expects its coronavirus vaccine to be ready by the first half of 2021 if production and supply goes smoothly


Reuters
May 28, 2020
GSK is working on its own COVID vaccine with French drugmaker Sanofi, one of the many projects to counter the respiratory illness that currently that has no treatment and has killed about 350,000 people


Rupa Burman Roy
May 19, 2020
European markets fell in trade today as investors turned cautious over bleak economic data and feared of the second wave of infections amid re-opening of many countries from lockdown


PTI
May 19, 2020
UN Secretary-General Antonio Guterres welcomed the ambitious, science-based actions from leading companies who are demonstrating to policy-makers that green growth remains the best growth strategy


PAGES 3 OF 4  1234